Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$28.47 USD
+0.38 (1.35%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $28.47 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Castle Biosciences, Inc. [CSTL]
Reports for Purchase
Showing records 1 - 20 ( 46 total )
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for CSTL 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
3Q23 Earnings Exceed with Diverse Menu Offsetting SCC
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Inside Castle''s Bridge to Wide 2025 Diagnostic Portfolio
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
2Q23 Earnings - Molecular Dx Portfolio Delivering
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Complete Turnaround ADLT Status for DecisionDx-SCC
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Disappointing Decision on SCC Test, but Company Reiterates Revenue Guide
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Pittsburg Lab Visit for Grand Opening of Tissue Cypher and SCC Expansion
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
2023 KBCM Life Sciences & MedTech Forum: Day 2 Takeaways
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Castle Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Positive Announcements Rolling Out at JPM
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department